No black box warning on record for Azathioprine Sodium

As of the latest FDA labeling reviewed, Azathioprine Sodium (AZATHIOPRINE SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Azathioprine Sodium medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Malignancy: Patients receiving immunosuppressants, including azathioprine, are at increased risk of developing lymphoma and other malignancies, particularly of the skin. Physicians should inform patients of the risk of malignancy with azathioprine. As usual for patients with increased risk for skin cancer, exposure to sunlight and ultraviolet light should be limited by wearing protective

No black box warning on record for Azathioprine Sodium

Other warnings & precautions

WARNINGS Malignancy: Patients receiving immunosuppressants, including azathioprine, are at increased risk of developing lymphoma and other malignancies, particularly of the skin. Physicians should inform patients of the risk of malignancy with azathioprine. As usual for patients with increased risk for skin cancer, exposure to sunlight and ultraviolet light should be limited by wearing protective

Azathioprine Sodium Black Box Warning

No black box warning on record for Azathioprine Sodium

Other warnings & precautions

Azathioprine Sodium Black Box Warning

No black box warning on record for Azathioprine Sodium

Other warnings & precautions